Last updated on November 2018

Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPSC001 in NETs


Brief description of study

The purpose of this clinical phase I/II study is to investigate the safety and tolerability of 177Lu-OPS201 used for the treatment of patients with neuroendocrine tumors (NETs). Secondary objectives of these study are the assessment of biodistribution, dosimetry and preliminary efficacy of 177Lu-OPS201.

Clinical Study Identifier: NCT02592707

Contact Investigators or Research Sites near you

Start Over

Ipsen Recruitment Enquiries

University Hospital Aarhus, Department of Hepatology and Gastroenterology
Aarhus, Denmark
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.